Oragenics, Inc. OGEN

Full chart Compare
Set alert

Price alert · OGEN

All alert types
0.35 USD -0.02 (-6.18%)

At closeNov 5, 2026, 4:00 PM EST

0.39 +0.04 +11.00%

After hours · Nov 5, 4:00 PM ET

0.3441 Day range 0.3622
0.3441 52-week range 1.22
YTD
-55.26%
1 year
-69.39%

Revenue & Expenses

Other Income → Expenses: $279.76KExpenses → Selling, General & Admin: $5.45MExpenses → Research & Development: $15.49MExpenses → Interest Expense: $30.59KGross Profit → Expenses: $37.65KRevenue → Gross Profit: $37.65KNet Loss → Expenses: $20.66MOther Income$279.76KGross Profit$37.65KNet Loss$20.66MExpenses$20.97MSelling, General & Admin$5.45MResearch & Development$15.49MInterest Expense$30.59KRevenue$37.65K

Latest period ending Dec 31, 2025 · select a line to chart its full history

Annual income statement

OGEN annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
9.36M10.56M20.94M14.55M15.86M
2.39M4.11M15.49M10.07M10.59M
6.97M6.44M5.45M4.48M5.27M
-9.36M-10.56M-20.90M-14.42M-15.77M
785.93K29.83K30.59K15.10K15.76K
-136.91K0000
-9.84M-10.57M-20.66M-14.29M-15.71M
-9.84M-10.57M-20.66M-14.29M-15.71M
-9.84M-10.57M-20.66M-14.29M-15.71M
-9.84M-10.57M-20.66M-14.29M-15.71M
-4.56-47.88-275.00-213.00-243.00
-4.56-47.88-275.00-213.00-243.00
-4.56-47.88-275.00-213.00-243.00
-9.19M-10.54M-20.63M-14.27M-15.70M
-9.19M-10.54M-20.63M-14.27M-15.70M
2.16M220.73K74.99K66.97K64.77K
2.16M220.73K74.99K66.97K64.77K